Cortiment Use In Pregnancy & Lactation





DCH Auriga - Universal
Four Star
Full Prescribing Info
Use In Pregnancy & Lactation
Use in Pregnancy: Data on use of inhaled budesonide in a very large number of exposed pregnancies indicate no adverse effects. Although there are no data of outcomes of pregnancies after oral administration, the bioavailability after oral administration is low. In animal experiments, at high exposures, corticosteroids proved to be harmful (see Pharmacology: Toxicology: Preclinical Safety Data under Actions). CORTIMENT should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus.
Fertility: There is no data on the effect of CORTIMENT on fertility in humans. There were no effects on fertility in rats after treatment with budesonide.
Use in Lactation: Budesonide is excreted in small amounts in breast milk. Due to the rapid budesonide clearance from the blood, on theoretical grounds, the exposure to the suckling child is expected to be low. However, there are no data. A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from budesonide therapy taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in